Manan B. Shah, PharmD, PhD

home / authors / manan-b-shah-pharmd-phd

Articles

January 22nd 2013

Predicting Asthma Outcomes in Commercially Insured and Medicaid Populations

Richard H. Stanford, PharmD, MS Manan B. Shah, PharmD, PhD Anna O. D'Souza, BPharm, PhD Michael Schatz, MD, MS

The controller-to-total asthma medication ratio was a significant predictor of exacerbations in pediatric and adult commercially insured and Medicaid patients.

September 14th 2012

Outcomes Associated With Timing of Maintenance Treatment for COPD Exacerbation

Anand A. Dalal, PhD, MBA Manan B. Shah, PharmD, PhD Anna O. D'Souza, BPharm, PhD Amol D. Dhamane, BPharm, MS Glenn D. Crater, MD

Early initiation of maintenance medication in patients with moderate to severe COPD exacerbations is associated with reduced risk of future exacerbations and lower costs.

May 1st 2008

Comparative Analysis of Alpha-blocker Utilization in Combination With 5-Alpha Reductase Inhibitors for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men

Muta M. Issa, MD, MBA Pei-Jung Lin, PhD Michael T. Eaddy, PharmD, PhD Manan B. Shah, PharmD, PhD E. Anne Davis, PharmD, MS

May 1st 2008

Dutasteride vs Finasteride: Assessment of Differences in Acute Urinary Retention Rates and Surgical Risk Outcomes in an Elderly Population Aged ≥65 Years

Thomas C. Fenter, MD E. Anne Davis, PharmD, MS Manan B. Shah, PharmD, PhD Pei-Jung Lin, PhD

February 1st 2007

A Large Retrospective Analysis of Acute Urinary Retention and Prostate-related Surgery in BPH Patients Treated with 5-alpha Reductase Inhibitors: Dutasteride Versus Finasteride

Muta M. Issa, MD, MBA M. Chris Runken, PharmD Amy L. Grogg, PharmD Manan B. Shah, PharmD, PhD

March 1st 2006

The Cost of Treating the 10 Most Prevalent Diseases in Men 50 Years of Age and Older

Thomas C. Fenter, MD Michael James Naslund, MD, MBA Manan B. Shah, PharmD, PhD Michael T. Eaddy, PharmD, PhD Libby Black, PharmD